CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 2, 2009
Result type: Reports
Project Number: SR0187-000
Product Line: Reimbursement Review

Generic Name: Abatacept

Brand Name: Orencia

Manufacturer: Bristol-Myers Squibb Canada

Therapeutic Area: Arthritis, Rheumatoid

Indications: Arthritis, Rheumatoid

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: June 17, 2010

Recommendation Type: List in a similar manner